Periostin, a matrix protein, is a novel biomarker for idiopathic interstitial pneumonias

Masaki Okamoto(Kurume University), Tomoaki Hoshino(Kurume University), Yasuhiko Kitasato(Kurume University), Yuka Sakazaki(University of the Ryukyus), T. Kawayama(Kurume University), Kiminori Fujimoto(Kurume University), Koichi Ohshima(Saga Medical School Hospital), Hiroshi Shiraishi(Kurume University), Masaru Uchida(Kurume University), Junya Ono(Shino-Test Corporation), Shoichiro Ohta(Saga Medical School Hospital), Seiya Kato(Kurume University), Kenji Izuhara(Saga Medical School Hospital), Hisamichi Aizawa(University of the Ryukyus)
European Respiratory Journal
December 22, 2010
Cited by 222Open Access
Full Text

Abstract

Idiopathic interstitial pneumonias (IIPs) are histopathologically classified into several types, including usual interstitial pneumonia (UIP), nonspecific interstitial pneumonia (NSIP) and cryptogenic organising pneumonia (COP). We investigated whether periostin, a matrix protein, could be used as a biomarker to assess histopathological types of IIPs. We performed immunohistochemical analyses in each histopathological type of IIP, examined serum levels of periostin in IIP patients and analysed the relationship between serum levels of periostin and the pulmonary functions in patients with idiopathic pulmonary fibrosis (IPF). Periostin was strongly expressed in lungs of UIP and fibrotic NSIP patients, whereas expression of periostin was weak in the lungs of cellular NSIP and COP patients, as well as in normal lungs. Serum levels of periostin in IPF were significantly higher than those of healthy subjects and COP patients. Furthermore, periostin levels in IPF patients were inversely correlated with their pulmonary functions. Thus, we have found that periostin is a novel component of fibrosis in IIP. Periostin may be a potential biomarker to distinguish IIP with fibrosis.


Related Papers

No related papers found

Powered by citation graph analysis